​

argenx SE (ARGX) Stock Forecast, Price Target & Predictions

OverviewOwnershipChartTranscripts

ARGX Stock Forecast

argenx SE (ARGX) stock forecast, based on 36 Wall Street analysts, predicts a 12-month average price target of $1,132.13, with a high of $1,350.00 and a low of $940.00. This represents a 22.45% increase from the last price of $924.60.

$350 $550 $750 $950 $1 $1 High: $1350 Avg: $1132.13 Low: $940 Last Closed Price: $924.6

ARGX Stock Rating

argenx SE stock's rating consensus is Buy, based on 36 Wall Street analysts. The breakdown includes 1 Strong Buy (2.78%), 30 Buy (83.33%), 5 Hold (13.89%), 0 Sell (0.00%), and 0 Strong Sell (0.00%).

Buy
Total 36 5 30 1 Strong Sell Sell Hold Buy Strong Buy

ARGX Price Target Upside V Benchmarks

TypeNameUpside
Stockargenx SE22.45%
SectorHealthcare Stocks 15.45%
IndustryBiotech Stocks 41.48%

Price Target Trends

1M3M12M
# Anlaysts71638
Avg Price Target$1.12K$1.13K$1.06K
Last Closing Price$924.60$924.60$924.60
Upside/Downside20.62%22.69%14.46%
Ratings Trends
DateStrong BuyBuyHoldSellStrong SellTotal
Jul, 267153--25
Jun, 266153--24
May, 266153--24
Apr, 265153--23
Mar, 265152-123
Analyst Price Target Forecasts
DateAnalystCompanyPrice TargetPrice when PublishedPrice Target/Price when PublishedPrice Target/Last Closing Price
Jul 24, 2026Morgan Stanley$1.20K$916.6930.91%29.79%
Jul 24, 2026Oppenheimer$1.04K$923.2612.32%12.16%
Jul 24, 2026Leerink Partners$1.06K$924.6015.18%15.18%
Jul 24, 2026Guggenheim$1.19K$924.6028.16%28.16%
Jul 24, 2026Wells Fargo$1.35K$924.6046.01%46.01%
Jul 23, 2026RBC Capital$1.02K$924.6010.86%10.86%
Jul 07, 2026RBC Capital$945.00$916.803.08%2.21%
Jun 24, 2026Luca IssiRBC Capital$890.00$855.843.99%-3.74%
Jun 24, 2026Sean LaamanMorgan Stanley$1.18K$869.4135.72%27.62%
Jun 04, 2026Douglas TsaoH.C. Wainwright$940.00$813.1415.60%1.67%
Analyst Rating Forecasts
DateCompanyPrevious RatingNew RatingRating Change
Jul 24, 2026BarclaysOverweightOverweighthold
Jul 24, 2026Morgan StanleyOverweightOverweighthold
Jul 24, 2026OppenheimerOutperformOutperformhold
Jul 24, 2026H.C. WainwrightBuyBuyhold
Jul 24, 2026GuggenheimBuyBuyhold
Jul 24, 2026Wells FargoOverweightOverweighthold
Jul 24, 2026CitigroupMarket OutperformMarket Outperformhold
Jul 23, 2026RBC CapitalOutperformOutperformhold
Jul 21, 2026CitigroupBuyBuyhold
Jul 03, 2026Deutsche BankBuyBuyhold

Financial Forecast

EPS Forecast

$-20 $-7 $6 $19 $32 $45 Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$-7.99$-13.05$-5.16-----
Avg Forecast$-6.93$-13.84$-4.27$2.19$9.99$18.54$26.94$34.47
High Forecast$-6.13$-10.14$-3.65$3.24$17.75$35.69$34.50$42.05
Low Forecast$-8.38$-16.90$-6.65$0.91$3.87$7.41$13.79$24.60
Surprise %15.30%-5.71%20.84%-----

Revenue Forecast

$0 $2B $3B $5B $6B $8B Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$497.28M$410.75M$1.23B-----
Avg Forecast$510.21M$441.26M$1.21B$2.17B$3.32B$4.40B$5.38B$6.49B
High Forecast$592.33M$516.41M$1.22B$2.20B$3.80B$4.52B$5.54B$7.58B
Low Forecast$464.78M$350.58M$1.18B$2.14B$2.82B$4.28B$5.21B$5.06B
Surprise %-2.54%-6.92%1.38%-----

Net Income Forecast

$-1B $-300M $400M $1B $2B $3B Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$-408.26M$-709.59M$-295.05M-----
Avg Forecast$-396.15M$-173.12M$-268.11M$118.49M$647.04M$1.30B$1.79B$1.97B
High Forecast$-350.29M$-54.70M$-84.72M$185.18M$1.01B$2.04B$1.97B$2.40B
Low Forecast$-479.04M$-291.53M$-451.51M$51.81M$221.00M$423.47M$788.32M$1.41B
Surprise %3.06%309.90%10.05%-----

ARGX Forecast FAQ

Is argenx SE stock a buy?

argenx SE stock has a consensus rating of Buy, based on 36 Wall Street analysts. The rating breakdown includes 1 Strong Buy, 30 Buy, 5 Hold, 0 Sell, and 0 Strong Sell, reflecting a consensus that argenx SE is a favorable investment for most analysts.

What is argenx SE's price target?

argenx SE's price target, set by 36 Wall Street analysts, averages $1.13K over the next 12 months. The price target range spans from $940 at the low end to $1.35K at the high end, suggesting a potential 22.45% change from the previous closing price of $924.6.

How does argenx SE stock forecast compare to its benchmarks?

argenx SE's stock forecast shows a 22.45% upside, outperforming the average forecast for the healthcare stocks sector (15.45%) and underperforming the biotech stocks industry (41.48%).

What is the breakdown of analyst ratings for argenx SE over the past three months?

  • July 2026: 28.00% Strong Buy, 60.00% Buy, 12.00% Hold, 0% Sell, 0% Strong Sell.
  • June 2026: 25.00% Strong Buy, 62.50% Buy, 12.50% Hold, 0% Sell, 0% Strong Sell.
  • May 2026: 25.00% Strong Buy, 62.50% Buy, 12.50% Hold, 0% Sell, 0% Strong Sell.

What is argenx SE’s EPS forecast?

argenx SE's average annual EPS forecast for its fiscal year ending in December 2024 is $2.19, marking a -142.44% decrease from the reported $-5.16 in 2023. Estimates for the following years are $9.99 in 2025, $18.54 in 2026, $26.94 in 2027, and $34.47 in 2028.

What is argenx SE’s revenue forecast?

argenx SE's average annual revenue forecast for its fiscal year ending in December 2024 is $2.17B, reflecting a 76.93% increase from the reported $1.23B in 2023. The forecast for 2025 is $3.32B, followed by $4.4B for 2026, $5.38B for 2027, and $6.49B for 2028.

What is argenx SE’s net income forecast?

argenx SE's net income forecast for the fiscal year ending in December 2024 stands at $118.49M, representing a -140.16% decrease from the reported $-295M in 2023. Projections indicate $647.04M in 2025, $1.3B in 2026, $1.79B in 2027, and $1.97B in 2028.